Discontinuation report AMITRIPTYLINE
Report ID | 66495 |
Drug Identification Number | 02451794 |
Brand name | AMITRIPTYLINE |
Common or Proper name | AMITRIPTYLINE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | AMITRIPTYLINE HYDROCHLORIDE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1000 |
ATC code | N06AA |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-01-07 |
Actual discontinuation date | 2019-01-07 |
Remaining supply date | 2019-01-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-11-09 | English | Compare |
v2 | 2018-11-09 | French | Compare |
v3 | 2019-09-18 | English | Compare |
v4 | 2019-09-18 | French | Compare |
Showing 1 to 4 of 4